HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yibin Yang Selected Research

aerolysin

12/2021Luteolin decreases the pathogenicity of Aeromonas hydrophila via inhibiting the activity of aerolysin.
4/2020Thymol Protects Channel Catfish from Aeromonas hydrophila Infection by Inhibiting Aerolysin Expression and Biofilm Formation.
11/2017Magnolol protects channel catfish from Aeromonas hydrophila infection via inhibiting the expression of aerolysin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yibin Yang Research Topics

Disease

10Neoplasms (Cancer)
10/2022 - 07/2011
7Infections
01/2022 - 07/2009
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2016 - 06/2012
2Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
10/2022 - 01/2018
2Inflammation (Inflammations)
08/2021 - 01/2020
2Body Weight (Weight, Body)
01/2021 - 04/2016
2Hodgkin Disease (Hodgkin's Disease)
11/2020 - 01/2020
2Lymphoma (Lymphomas)
04/2014 - 06/2012
1Malignant Pleural Effusion
01/2022
1Hemolysis
12/2021
1Pneumonia (Pneumonitis)
01/2021
1Communicable Diseases (Infectious Diseases)
04/2020
1Adenocarcinoma of Lung
01/2020
1COVID-19
01/2020
1Virus Diseases (Viral Diseases)
01/2020
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2019
1Multiple Myeloma
10/2019
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2019
1Insulin Resistance
10/2017
1Mitochondrial Diseases (Mitochondrial Disease)
10/2017
1Acute Kidney Injury (Acute Renal Failure)
10/2015
1Tuberculosis (Tuberculoses)
07/2009
1Crohn Disease (Crohn's Disease)
09/2007

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
11/2020 - 09/2007
5UbiquitinIBA
11/2020 - 07/2011
4Pharmaceutical PreparationsIBA
01/2022 - 01/2016
4Phosphotransferases (Kinase)IBA
11/2020 - 09/2007
4Transcription Factors (Transcription Factor)IBA
01/2018 - 07/2011
3aerolysinIBA
12/2021 - 11/2017
3Biomarkers (Surrogate Marker)IBA
01/2020 - 10/2015
2RNA (Ribonucleic Acid)IBA
01/2020 - 01/2020
2CytokinesIBA
05/2014 - 09/2007
1palbociclibIBA
10/2022
1eprenetapoptIBA
10/2022
1Mechanistic Target of Rapamycin Complex 1IBA
10/2022
1HexokinaseIBA
01/2022
1interleukin 20 (IL-20)IBA
08/2021
1ArginaseIBA
08/2021
1tiamulinIBA
01/2021
1ThymolIBA
04/2020
1Anti-Bacterial Agents (Antibiotics)IBA
04/2020
1Long Noncoding RNAIBA
01/2020
1Brentuximab VedotinIBA
01/2020
1Interleukin-22 (IL-22)IBA
01/2020
1EnzymesIBA
01/2020
1InterleukinsIBA
01/2020
1Anaplastic Lymphoma KinaseIBA
11/2019
1Programmed Cell Death 1 ReceptorIBA
11/2019
1Immunoglobulin G (IgG)IBA
10/2019
1elotuzumabIBA
10/2019
1Monoclonal AntibodiesIBA
10/2019
1Immune Checkpoint InhibitorsIBA
01/2019
1pembrolizumabIBA
01/2019
1B7-H1 AntigenIBA
01/2019
1Copper Sulfate (Sulfate, Copper)FDA Link
12/2018
1ChromatinIBA
01/2018
1magnololIBA
11/2017
1GTP Phosphohydrolases (GTPases)IBA
10/2017
1NLR ProteinsIBA
10/2017
1Uric Acid (Urate)IBA
01/2017
1Lysine (L-Lysine)FDA Link
01/2016
1Histone DemethylasesIBA
01/2016
1histone H3 trimethyl Lys4IBA
01/2016
1Histones (Histone)IBA
01/2016
1venetoclaxIBA
12/2015
1Interleukin-1 Receptor-Associated KinasesIBA
12/2015
1Agammaglobulinaemia Tyrosine KinaseIBA
12/2015
1ibrutinibIBA
12/2015
1Deubiquitinating EnzymesIBA
01/2015
1Ligases (Synthetase)IBA
01/2015
1Receptor-Interacting Protein Serine-Threonine Kinase 2 (CARDIAK)IBA
05/2014
1Conditioned Culture MediaIBA
05/2014
1ChemokinesIBA
05/2014
1Lenalidomide (CC 5013)FDA Link
06/2012
1InterferonsIBA
06/2012
1Interferon Type IIBA
07/2009
1Toll-Like Receptors (Toll-Like Receptor)IBA
07/2009
1Peptidoglycan (Murein)IBA
07/2009
1PolyubiquitinIBA
09/2007
1NucleotidesIBA
09/2007
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
09/2007
1I-kappa B KinaseIBA
09/2007

Therapy/Procedure

5Therapeutics
10/2022 - 07/2011
2Oral Administration
01/2021 - 04/2016
1Length of Stay
01/2021
1Immunotherapy
11/2019
1Intravenous Administration
04/2016
1Drug Therapy (Chemotherapy)
01/2016